It is a automotive private limited company based in Vijayawada, Andhra Pradesh, India, established in 2019.
2019 | Vijayawada, Andhra Pradesh, India | ActiveIros Pharma Private Limited, a active private limited company, was established on 16 September 2019 in Vijayawada, Andhra Pradesh, India. Engaging in auto parts & components within the trade sector, it holds CIN: U24299AP2019PTC112905. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Deepa Baddela (Managing Director), Yunus Mohammed Karim (Additional Director). Past directors included Deepa Baddela, Somnath Adduri, Reshma Bhavya Adduri. Its latest AGM occurred on 13 September 2022, with the balance sheet filed on 31 March 2022. It is based at D. No. 4-36-88B, Viswa Brahmin Street, Milk Project,, Vijayawada, Andhra Pradesh, 520001.
U24299AP2019PTC112905
112905
16 September 2019
₹0.50 M
₹0.50 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Iros Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepa Baddela | Managing Director | 25 Jan 2023 | Current |
| Yunus Mohammed Karim | Additional Director | 18 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Jan 2023 | Past |
| Pramod Abcsdd | Director | 18 May 2025 | Past |
| Pramod Abcsdd | Director | 18 May 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Iros Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.67% increase. The company also saw a substantial improvement in profitability, with a 11.21% increase in profit. The company's net worth Soared by an impressive increase of 15.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Iros Pharma had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Iros Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Iros Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iros Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Yunus Mohammed Karim was appointed as a Additional Director was appointed as a Additional Director on 18 May 2025 & has been associated with this company since 6 months 14 days . was recorded as a recent event.
The activity Deepa Baddela was appointed as a Managing Director was appointed as a Managing Director on 25 Jan 2023 & has been associated with this company since 2 years 10 months . was completed.
The activity Iros Pharma Private Limited last Annual general meeting of members was held on 13 Sep 2022 as per latest MCA records. was completed.
Iros Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada. was recorded as a recent event.
Iros Pharma Private Limited was registered on 16 Sep 2019 with Roc Vijayawada & aged 6 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Iros Pharma Private Limited is U24299AP2019PTC112905.
Iros Pharma Private Limited is headquartered at D. No. 4-36-88B, Viswa Brahmin Street, Milk Project,, Vijayawada, Andhra Pradesh, 520001.
Iros Pharma Private Limited was incorporated on 16 September 2019.
The current directors of Iros Pharma Private Limited are
The primary industry of Iros Pharma Private Limited is Trade.
Iros Pharma Private Limited is unlisted.
The authorized capital of Iros Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX